Genpharmasec Ltd — Board Meeting, 06-11-2025: Board Meeting
06-11-2025 | 07:47 pm
06-11-2025 | 07:47 pm
Genpharmasec board approved its Q2 & H1 FY25 financial results. Standalone net profit was ₹0.82 Cr for the quarter and ₹2.38 Cr for the half-year. Consolidated results showed a quarterly net loss of ₹1.18 Cr, with a half-year net loss of ₹0.14 Cr.
No comments yet. Be the first to comment!
